0e9cbf1f F762 4825 845c Fe44b8c04e0b 400 2
Rabeprazole Sodium
Product Images NDC 50090-3182
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 50090-3182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structure (4d1e141f 24d6 41e0 A671 48ff69147297 01)
Chemical structure of rabeprazole sodium showing its molecular framework including a sulfoxide group, a pyridine ring, and an indazole ring with associated sodium ion.*
Figure 2 (4d1e141f 24d6 41e0 A671 48ff69147297 02)
A line graph titled 'Mean Daytime Heartburn Scores RAB-USA-2' showing mean heartburn scores on the vertical axis from 0 to 4 and study days on the horizontal axis ranging from -14 to 28. Three groups are compared: Placebo (n=68), Rabeprazole 10 mg (n=64), and Rabeprazole 20 mg (n=67). The graph shows heartburn scores decreasing over time, with both Rabeprazole groups showing a greater reduction than placebo after day 0.*
Figure 3 (4d1e141f 24d6 41e0 A671 48ff69147297 03)
A line graph titled 'Mean Nighttime Heartburn Scores RAB-USA-2' showing mean heartburn scores over a study period of 28 days. The x-axis represents study days from -14 to 28, and the y-axis shows mean scores from 0 to 4. Three lines represent Placebo (n=68), Rabeprazole sodium 10 mg (n=64), and 20 mg (n=67), with scores generally decreasing after day 0.*
Figure 4 (4d1e141f 24d6 41e0 A671 48ff69147297 04)
A line graph titled 'Mean Daytime Heartburn Scores RAB-USA-3' comparing mean heartburn scores over a study period of 42 days between a placebo group (n=58) and a Rabeprazole 20 mg group (n=59). The x-axis shows study days from -14 to 28, and the y-axis shows heartburn scores ranging from 0 (None) to 4 (Very Severe). The graph indicates a decrease in mean heartburn scores over time, with the Rabeprazole 20 mg group showing lower scores compared to placebo after day 0.*
Figure 5 (4d1e141f 24d6 41e0 A671 48ff69147297 05)
A line chart titled 'Mean Nighttime Heartburn Scores RAB-USA-3' comparing two groups: Placebo (n=58) and Rabeprazole sodium 20 mg (n=59) over a 28-day study period. The y-axis represents mean heartburn scores from 0 (none) to 4 (very severe), and the x-axis shows study days from -14 to 28. The chart illustrates changes in heartburn severity for both groups throughout the study.*
Logo (4d1e141f 24d6 41e0 A671 48ff69147297 06)
Label Image (Lbl500903182)
Label for Rabeprazole Sodium 20 mg release tablets by A-S Medication Solutions. The label includes product and lot numbers, storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from moisture, and a quantity of 30 tablets. Packaging details and a barcode are also visible.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
